Home  »  Industry   »  TEVA’s Stock Journey: What Investors Need to...

TEVA’s Stock Journey: What Investors Need to Know About Teva Pharmaceutical Industries Limited’s Performance

Currently, the stock price of Teva Pharmaceutical Industries Limited (TEVA) is $10.55. In the most recent trading session, the stock underwent a significant upswing, peaking at $10.66 after opening at $10.54. The stock touched a low of $10.53 before closing at $10.59.

Teva Pharmaceutical Industries Limited’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $11.44 on 01/12/23, and the lowest price during that time was $7.09, recorded on 05/31/23.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free

52-week price history of TEVA Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Teva Pharmaceutical Industries Limited’s current trading price is -7.86% away from its 52-week high, while its distance from the 52-week low is 48.84%. The stock’s price range during this period has fluctuated between $7.09 and $11.44. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 3.1 million for the day, which was evidently lower than the average daily volume of 9.84 million over the last three months.

Financial Performance and Market Capitalization

Teva Pharmaceutical Industries Limited (TEVA) has experienced a quarterly rise of 39.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 11.78B and boasts a workforce of 34004 employees.

Analysts’ Ratings For Teva Pharmaceutical Industries Limited

As of right now, 3 analysts are rating Teva Pharmaceutical Industries Limited as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 7 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 2 analysts are rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.56, with a change in price of +2.36. Similarly, Teva Pharmaceutical Industries Limited recorded 11,776,341 in trading volume during the last 100 days, posting a change of +28.61%.

TEVA Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 2.93. Similarly, the long-term debt-to-equity ratio is also 2.65.

TEVA Stock Stochastic Average

The raw stochastic average for Teva Pharmaceutical Industries Limited over the last 50 days is presently at 97.38%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 94.64%. Further, the company’s Stochastic %K and %D values for the last 20 days were 95.82% and 95.65%, respectively.

TEVA Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price increase of 15.63%. However, over the past six months, we’ve seen a weaker performance of 26.14%. The price of TEVA fallen by 10.88% over the last 30 days. And in the last five days, it has surged by 5.03%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts